Clinical Performance Study of the ABTest Card® Device.

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Transfusion Reaction
Interventions
DIAGNOSTIC_TEST

ABTest Card®REF and ABTest Card®NEW

Pre transfusional control with the ABTest Card®REF device (predicate device) and the ABTest Card®NEW device (investigational device).

Trial Locations (1)

Unknown

CHU Orléans, Orléans

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Soladis

INDUSTRY

lead

Diagast

INDUSTRY

NCT06557031 - Clinical Performance Study of the ABTest Card® Device. | Biotech Hunter | Biotech Hunter